Dr. Stephen Hahn
Source: The University of Texas MD Anderson Cancer Center.
Senators grilled Dr. Stephen Hahn, President Donald Trump’s nominee to run the Food and Drug Administration, over how he would tackle the teen vaping epidemic at his confirmation hearing Wednesday.
Facing new data showing more than one-quarter of high school students vape, the Trump administration in September announced it was readying a ban on all flavors of e-cigarettes except tobacco. Trump has since reportedly backed off the plan amid pressure from conservatives and the vaping community, drawing sharp criticism from Democrats and public health advocates.
Sen. Patty Murray, D-Wash., and ranking member of the Senate Health, Education, Labor and Pensions committee, said Trump’s apparent backtracking shows he’s “more swayed by the tobacco industry and politics than by children’s health.”
“We need an FDA commissioner who will push back hard to put children’s health first,” Murray said.
She pressed Hahn on whether he was committed to finalizing a ban on flavored e-cigarettes. Hahn touted his experience as a lung cancer doctor, saying he has seen the “ravages” of tobacco firsthand. He said “aggressive action” is needed to prevent another generation of Americans becoming addicted to nicotine but stopped short of committing to pushing the president to ban flavors.
“I understand the final compliance is under consideration by the administration,” Hahn said. “I look forward to their decision. I am not privy to those decision making processes, but I very much am in support of aggressive action to protect our children.”
Hahn said he has not had a conversation with Trump about the flavor ban. In an exchange with Sen. Mitt Romney, R-Utah, Hahn said he does not want to “pre-judge” the policy because he does not have “all the facts they might have.”
“I can tell you this, for sure, sir, I will use science and data to guide the decisions if I’m fortunate enough to be confirmed, and I won’t back away from that,” Hahn said.
Hahn is an oncologist and chief medical executive at Texas’ MD Anderson Cancer Center.